亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北省帝鑫化工制造有限公司  

醫藥原料及中間體、植物提取物、動植物提取物等

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:胡鑫
  • 電話:027-51013021
  • 郵件:dxhg007@163.com
  • 傳真:027-67880806
  • QQ:1036188341
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 現貨供應高純度托曲珠利原料藥廠家
現貨供應高純度托曲珠利原料藥廠家
單價 1.00 / 千克對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 5000千克起訂25千克
品牌 帝鑫
過期 長期有效
更新 2016-01-14 16:09
 
詳細信息
 
中文名:托曲珠利 
英文名稱:1-METHYL-3-[3-METHYL-4-[4-(TRIFLUOROMETHYLTHIO)PHENOXY]PHENYL]-1,3,5-TRIAZINE-2,4,6(1H,3H,5H)-TRIONE,BAYCOX,TOLTRAZURIL
中文名稱:1-[3-甲基-4-(4-三氟甲硫基-苯氧基)-苯基]-3-甲基-1,3,5-三嗪-2,4,6-三酮,托曲珠利,***三嗪酮
 
CAS:69004-03-1 
分子式:C18H14F3N3O4S 
分子量:425.38 
 
托曲珠利 理化性質
 氟含量:≥12.0% 
 熔點:193- 196℃ 
 熾灼殘渣:≤0.1% 
 氧化物:≤0.02% 
 重金屬:≤10ppm 
 干燥失重:≤0.5%
 
性狀:白色或類白色結晶粉末。
用途:廣譜抗球蟲原料藥,家禽上妥曲珠利主用于家禽球蟲病。
©2025 湖北省帝鑫化工制造有限公司 版權所有   技術支持:化工網   訪問量:40466  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |